SCHEMBL20188060

SCHEMBL20188060

COc1ccc(Br)cc1NC(=O)c1ccco1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.74
KMT2A Q03164 5/20 0.73
HSD17B10 Q99714 5/20 0.73
KDM4E B2RXH2 6/20 0.70
HPGD P15428 3/20 0.70
SMN1; SMN2 Q16637 2/20 0.70
HTT P42858 2/20 0.70
MAPT P10636 6/20 0.68
ALDH1A1 P00352 4/20 0.68
MEN1 O00255 3/20 0.68
LMNA P02545 3/20 0.68
NPSR1 Q6W5P4 3/20 0.67
MAPK1 P28482 2/20 0.67
USP2 O75604 1/20 0.67
GAA P10253 1/20 0.67
TP53 P04637 1/20 0.65
RAB9A P51151 2/20 0.63
NPC1 O15118 1/20 0.63
AHR P35869 1/20 0.62
ALOX15 P16050 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6638013 0.82 TSHR (0.73) TSHRKMT2AHSD17B10KDM4EHPGD
SCHEMBL20201167 0.81 KMT2A (0.51) TSHRKMT2AHSD17B10KDM4EHPGD
SCHEMBL28857643 0.80 PKM (0.72) KDM4ESMN1; SMN2HTTMAPTALDH1A1
SCHEMBL21880903 0.77 RAB9A (1.00) TSHRKMT2AHSD17B10KDM4EHPGD
SCHEMBL12214430 0.77 RAB9A (1.00) TSHRKMT2AHSD17B10KDM4EHPGD
SCHEMBL7294117 0.76 KDM4E (0.81) TSHRKMT2AHSD17B10KDM4EHPGD
SCHEMBL6933566 0.76 CYP1A2 (0.61) TSHRKMT2AHSD17B10KDM4EHPGD
SCHEMBL2322923 0.75 KMT2A (0.53) TSHRKMT2AHSD17B10KDM4ESMN1; SMN2
SCHEMBL14721362 0.75 ALDH1A1 (0.52) TSHRKMT2AHSD17B10KDM4ESMN1; SMN2
SCHEMBL20187795 0.75 KMT2A (0.47) TSHRKMT2AHSD17B10KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541792-B1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-12-23 EP disclosed
EP-3541792-B1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-12-23 EP disclosed
US-10736883-B2 Triazole furan compounds as agonists of the APJ receptor AMGEN INC. (US) 2020-08-11 US disclosed
US-10736883-B2 Triazole furan compounds as agonists of the APJ receptor AMGEN INC. (US) 2020-08-11 US disclosed
EP-3541792-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR Amgen Inc. (US) 2019-09-25 EP disclosed
US-20190275008-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2019-09-12 US disclosed
US-20190275008-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2019-09-12 US disclosed
WO-2018097944-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2018-05-31 WO disclosed
WO-2018097944-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190275008-A1 TRIAZOLE FURAN COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR TBXA2R, AGTR1, APLNR TSHR 379/4885KMT2A 4607/4885HSD17B10 1734/4885
US-10736883-B2 Triazole furan compounds as agonists of the APJ receptor TBXA2R, AGTR1, APLNR TSHR 379/4885KMT2A 4607/4885HSD17B10 1734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.